Summit Therapeutics
SMMT
SMMT
205 hedge funds and large institutions have $2.06B invested in Summit Therapeutics in 2025 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 75 increasing their positions, 65 reducing their positions, and 60 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
28% less call options, than puts
Call options by funds: $52.1M | Put options by funds: $72.2M
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
43% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 60
Holders
205
Holding in Top 10
3
Calls
$52.1M
Puts
$72.2M
Top Buyers
| 1 | +$90.9M | |
| 2 | +$83.6M | |
| 3 | +$50.2M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$42.8M |
| 5 |
BlackRock
New York
|
+$37.6M |
Top Sellers
| 1 | -$18.8M | |
| 2 | -$15.7M | |
| 3 | -$15.4M | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
-$11.4M |
| 5 |
CFM
Capricorn Fund Managers
London,
United Kingdom
|
-$10.3M |
